| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.19 | 0.0004 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |